TTS Ltd. and their co-sponsors the National Institutes of Health (NIH), BIO Maryland, the Maryland Biotechnology Center and John Hopkins Technology Transfer announce the 2nd Annual Tech Transfer Summit North America (TTSNA) in Bethesda, Maryland on 3-4 October 2011.
The TTSNA is a core pilar of the Global Tech Transfer Initiative, the leading global initiative for biotech sector industry-academia & SME partnering, licensing & collaboration meetings. The TTSNA is a must-attend event for all Technology Transfer, Commercialization, early stage SME, biotech, pharma and related sector licensing & technology executives and managers. It is the most relevant meeting for key technology transfer and commercialization officers, senior innovation & research directors from leading research universities, institutes, science parks and bioregions, the best opportunity of the year to meet leading pharma and biotech licensing executives looking to establish relationships and do deals with universities and research institutes. The TTSNA is where Tech Transfer Officers make the connections the enable them to best serve their institutions and build the relationships, networks, collaborations and licensing deals that will provide real value for their researchers and insittutions as a whole.
Outside the Box - Literally
Can you really think outside the box when you are actually in a box? The TTS Initiative Social Network (Powered by JuJaMa) is more than just a partnering system. It is a powerful platform which enables you to post your profile, highlight your technology, licensing and IP offers, search other participants by name, category, interest, source and review licensing offers, and communicate not just during, but prior to and following the Summit, setting up meetings on or off-site with the key contacts you need to meet.
The TTS is not a new event, it has has a proven Track Record over 5 years of Summits in key biotech regions around the world which confirms the consistent attendance of key industry executives, financial experts, alongside those from leading academic research universities and institutes, and cements the Summit’s role as the premier international platform for early stage activity in the biotech sector. Participation in the Summit is strictly limited to approximately 450 attendees and requires confirmed registration through the registration page.
Registration now open and total participation strictly limited -- click the Registration link at left for details and to reserve your place now!